...
首页> 外文期刊>Current drug discovery technologies >Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting
【24h】

Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting

机译:叶酸脑靶向鼻腔给药系统的研制与评价

获取原文
获取原文并翻译 | 示例

摘要

Nasal mucosa offers advantages to deliver drugs to brain via olfactory route thus provides rapid onset of drug action and hence faster therapeutic effect. Therefore, various strategies have been proposed to improve the delivery of different drugs to brain including liposomes, colloidal drug carriers, micelles, chimeric peptide technology and nanotechnology through nasal route. The low blood level of folates is the primary cause of depression in Alzheimer's disease. Folic acid is a water soluble vitamin showing difficulty in crossing the blood brain barrier and thus was formulated as niosomal nasal drug delivery systems to target the brain. In the present work, folic acid niosomes were prepared using different nonionic surfactants i.e., span 20, span 60, span 80, tween 20, tween 80 and cholesterol by using lipid layer hydration technique. These were evaluated for particle size, viscosity, osmotic shock, entrapment efficiency and in vitro drug release. The influence of different formulation variables such as surfactant type, surfactant concentration, and cholesterol concentration was optimized for required size distribution, viscosity, entrapment efficiency and in vitro release. The prepared niosomes were in the size range of 3.05-5.625μm. Niosomes prepared with span 60 and cholesterol in the ratio of 1:1(50mg: 50mg) shown higher entrapment efficiency of 69.42% and better in vitro drug release of 64.2% at the end of 12 hrs and therefore considered as optimized formulation. The stability studies were carried out by storing niosomes at 4±1°C and 25±1°C and showed good stability over the period of storage. The release of drug from niosomes followed anomalous diffusion and obeyed first order release kinetics. Ex-vivo perfusion studies were also performed by using rat model, about 48.15% of drug was found to be absorbed through nasal cavity at the end of 6 hrs.
机译:鼻粘膜具有通过嗅觉途径将药物输送到大脑的优势,因此可以迅速起效,从而具有更快的治疗作用。因此,已经提出了各种策略来改善通过鼻途径向脑中递送不同药物,包括脂质体,胶体药物载体,胶束,嵌合肽技术和纳米技术。叶酸水平低是阿尔茨海默氏病抑郁的主要原因。叶酸是一种水溶性维生素,在穿越血脑屏障方面显示出困难,因此被配制成靶向鼻部的鼻腔鼻给药系统。在本工作中,通过使用脂质层水化技术,使用不同的非离子表面活性剂,即跨度20,跨度60,跨度80,吐温20,吐温80和胆固醇,制备了叶酸类脂质体。对它们的粒度,粘度,渗透压,包封率和体外药物释放进行了评估。针对所需的尺寸分布,粘度,包封效率和体外释放,优化了不同配方变量(如表面活性剂类型,表面活性剂浓度和胆固醇浓度)的影响。制备的脂质体的大小范围为3.05-5.625μm。用跨度60和胆固醇以1:1(50mg:50mg)的比例制备的脂质体在12小时结束时表现出更高的包封效率69.42%,更好的体外药物释放64.2%,因此被认为是优化的制剂。稳定性研究是通过将脂质体在4±1°C和25±1°C下保存进行的,在整个保存期间显示出良好的稳定性。药物从脂质体中的释放遵循异常扩散并遵循一级释放动力学。还通过使用大鼠模型进行了离体灌注研究,发现约48.15%的药物在6小时结束时通过鼻腔吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号